Therefore, our study shows that the expression of PD-1 in T lymphocyte subsets, especially CD8+ T cells, can predict the short-term outcomes of patients with ESCC and that patients with lower PD-1 expression in the peripheral blood have better short-term outcomes. Here, PDCD1 is linked to esophageal squamous cell carcinoma.